Additionally, RFA-induced VEGF promotes tumor stemness and tumorigenesis via Nanog and activation of VEGFR2, which are positively correlated with CD133 expression in HCC tissues derived from patients with early recurrence. Here, PROM1 is linked to neoplasm.